dc.creatorThakur, Sidharath Dev
dc.creatorAraya, Pamela
dc.creatorBorthagaray, Graciela
dc.creatorGalarza, Patricia G.
dc.creatorHernandez, Alina Llop
dc.creatorPayares, Daisy
dc.creatorSanabria Cruz, Olga Marina
dc.creatorCarvallo, Maria Elena Trigoso
dc.creatorCorredor, Aura Helena
dc.creatorDillon, Jo-Anne R
dc.date2021-01-20T13:06:59Z
dc.date2021-01-20T13:06:59Z
dc.date2017
dc.date.accessioned2023-08-29T20:08:58Z
dc.date.available2023-08-29T20:08:58Z
dc.identifier1537-4521
dc.identifierhttps://europepmc.org/article/med/28178114
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/2190
dc.identifier10.1097/OLQ.0000000000000587
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8520432
dc.descriptionFil: Thakur, Sidharath Dev. Department of Microbiology, College of Medicine; Estados Unidos.
dc.descriptionFil: Araya, Pamela. Instituto de Salud Publica de Chile, Santiago; Chile.
dc.descriptionFil: Borthagaray, Graciela. Faculdad de Quimica, Universidad de la Republica, Montevideo; Uruguay.
dc.descriptionFil: Galarza, Patricia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Hernandez, Alina Llop. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Medicina Tropical; Argentina.
dc.descriptionFil: Payares, Daisy. Instituto Nacional Higiene "Rafael Rangel", Caracas; Venezuela.
dc.descriptionFil: Sanabria Cruz, Olga Marina. Instituto National de Salud, Bogota; Colombia.
dc.descriptionFil: Carvallo, Maria Elena Trigoso. Centro Departmental de Vigilancia Information y Referencia, CDVIR La Paz; Bolivia.
dc.descriptionFil: Corredor, Aura Helena. Vaccine and infectious Disease Organization-International Vaccine Center, University of Saskatchewan, Saskatchewan; Canada.
dc.descriptionFil: Dillon, Jo-Anne R. Vaccine and infectious Disease Organization-International Vaccine Center, University of Saskatchewan, Saskatchewan; Canada.
dc.descriptionSeven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%.
dc.formatpdf
dc.languageen
dc.publisherLippincott, Williams & Wilkins
dc.relationSexually transmitted diseases
dc.rightsopen
dc.sourceSexually Transmitted Diseases 2017; 44(3):157-160.
dc.subjectNeisseria gonorrhoeae
dc.subjectNeisseria
dc.titleResistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011
dc.typeArtículo


Este ítem pertenece a la siguiente institución